START San Antonio
Clinical research site in San Antonio, Texas · 7400 MERTON MINTER ST, SAN ANTONIO, TX 78229-4404 · (615) 355-3451
As of September 2026, 50 paid clinical trials are recruiting at START San Antonio in San Antonio, Texas. Active studies at this site cover conditions such as Advanced Solid Tumor, Advanced Solid Tumors and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at START San Antonio (50)
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
A Study of PYX-201 in Advanced Solid Tumors
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Study in Advanced Solid Tumor Patients
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
DPTX3186 in Wnt Pathway Activated Solid Tumors
A Study of ZW251 in Participants With Advanced Solid Tumors
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Showing the 40 most relevant of 50 recruiting trials at this site. Browse all with filters →
Get new-trial alerts for START San Antonio
We'll email you whenever a new clinical trial starts recruiting at this research site in San Antonio, TX. Unsubscribe anytime.
More research sites in San Antonio
- University of Texas Health Science Center at San Antonio (85 trials)
- NEXT Oncology (56 trials)
- Children's Hospital of San Antonio (30 trials)
- Methodist Children's Hospital of South Texas (23 trials)
- The University of Texas Health Science Center at San Antonio (21 trials)
- UT Health San Antonio (17 trials)
- Texas Dermatology and Laser Specialists (15 trials)
- GSK Investigational Site (14 trials)
- Texas Oncology - San Antonio (12 trials)
- Brooke Army Medical Center (12 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in San Antonio, TX · Texas clinical trials